Tat protein based HIV vaccine (Vaxxit)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTat protein based HIV vaccine (Vaxxit)
Drug Alias NameTatImmune
ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunomodulatorsHuman Immunodeficiency Virus tat Gene Products inhibitors
TargetsHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIstituto Biochimico Italiano Giovanni Lorenzini Spa
China Registration ClassN/A

Develop Information

Active CompaniesIstituto Biochimico Italiano Giovanni Lorenzini SpaVaxxit
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A